CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia

Borja Guerra(Universidad de Las Palmas de Gran Canaria), Leandro Fernández‐Pérez(Universidad de Las Palmas de Gran Canaria)

Oncotarget

August 19, 2016

10.18632/oncotarget.11425

Cited by 13

Related Papers

A Novel Naphthoquinone-Coumarin Hybrid That Inhibits BCR-ABL1-STAT5 Oncogenic Pathway and Reduces Survival in Imatinib-Resistant Chronic Myelogenous Leukemia Cells

|Frontiers in Pharmacology|2019|12